Sensitive detection of Plasmodium vivax malaria by the rotating-crystal magneto-optical method in Thailand - Orbán, Ágnes; Longley, Rhea J.; Sripoorote, Piyarat; Maneechai, Nongnuj; Nguitragool, Wang; Butykai, Adam; Mueller, Ivo; Sattabongkot, Jetsumon; Karl, Stephan; Kézsmárki, István (medRxiv, 2021)
The rotating-crystal magneto-optical detection (RMOD) method has been developed for the rapid and quantitative diagnosis of malaria and tested systematically on various malaria infection models. Very recently, an extended field trial in a high-transmission region of Papua New Guinea demonstrated its great potential for detecting malaria infections, in particular Plasmodium vivax. In the present small-scale field test, carried out in a low-transmission area of Thailand, RMOD confirmed malaria in all samples found to be infected with Plasmodium vivax by microscopy, our reference method. Moreover, the magneto-optical signal for this sample set was typically 1–3 orders of magnitude higher than the cut-off value of RMOD determined on uninfected samples. Based on the serial dilution of the original patient samples, we expect that the method can detect Plasmodium vivax malaria in blood samples with parasite densities as low as ~ 5 - 10 parasites per microliter, a limit around the pyrogenic threshold of the infection. In addition, by investigating the correlation between the magnitude of the magneto-optical signal, the parasite density and the erythrocytic stage distribution, we estimate the relative hemozoin production rates of the ring and the trophozoite stages of in vivo Plasmodium vivax infections.Competing Interest StatementThe authors have declared no competing interest.Funding StatementR.J.L is the recipient of an Australian National Health and Medical Research Council (NHMRC) Emerging Leadership Fellowship (GNT1173210). S.K. is a recipient of an NHMRC Career Development Fellowship (GNT1141441). A.B. and A.O. were supported by the BME-Nanotechnology and Materials Science FIKP grant of EMMI (BME FIKP-NAT) and NRDI Fund (TKP2020 IES, Grant No. BME-IE-NAT), Hungary.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study conducted in Thailand received ethical clearance from the Ethics Committee at the Faculty of Tropical Medicine, Mahidol University (MUTM 261 2013-027-01). The study was clearly explained to all volunteers and informed consent was obtained from all participants in the study. The study conducted in Papua New Guinea received ethical clearance by the PNG Institute of Medical Research (PNGIMR) Institutional Review Board and the PNG Medical Research Advisory Committee (MRAC, #16.45). All methods were carried out in accordance with the relevant guidelines and regulations of the named institutes.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available upon request from the corresponding author.